Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
UNIVERSITE PAUL SABATIER TOULOUSE III currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and 1 distinct art unit. The university's current prosecution activity is concentrated within a single technical domain. Practitioners should note that having 1 distinct art unit involved simplifies the tracking of relevant case law and examination trends. This focused approach is common for specialized research institutions targeting specific biological or pharmaceutical advancements.
The busiest examiner for this portfolio is LU, CHENG, who is handling 1 pending office action. This represents the total number of pending office actions for the university at this time. Because there is only 1 distinct examiner involved, the prosecution strategy is focused on a single point of contact at the patent office. The involvement of 1 distinct art unit suggests that the technical subject matter is being evaluated under a specific set of guidelines. This streamlined workload allows for a precise response to the pending matter. The presence of 1 busiest examiner pending 1 action indicates a very low volume of active prosecution for this entity.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LU, CHENG | 1 | 54.1% | +64.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| Art Unit | Apps |
|---|---|
| 1642 | 1 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial